Dose-response relationship of mannitol and intracranial pressure: A metaanalysis

Journal of Neurosurgery

Volumn 108, Issue 1, 2008, Pages 80-87

  Sorani, Marco D ^a   Manley, Geoffrey T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dose; Edema; Intracranial pressure; Mannitol; Metaanalysis

Indexed keywords

MANNITOL;

ARTICLE; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLASGOW COMA SCALE; HUMAN; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

DIURETICS, OSMOTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; INTRACRANIAL PRESSURE; MANNITOL;

EID: 38349025838     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/01/0080     Document Type: Article

References (32)

1. Andrews BT, Chiles BW III, Olsen WL, Pitts LH: The effect of intracerebral hematoma location on the risk of brain-stem compression and on clinical outcome. J Neurosurg 69:518-522, 1988
2. Battison C, Andrews PJ, Graham C, Petty T: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 33:196-202, 2005
3. Biestro A, Alberti R, Galli R, Cancela M, Soca A, Panzardo H, et al: Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol. Acta Neurochir (Wien) 139: 725-732, 1997
4. Brain Trauma Foundation: American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care: guidelines for the management of severe head injury. J Neurotrauma 13:641-734, 1996
5. Bullock R: Mannitol and other diuretics in severe neurotrauma. New Horiz 3:448-452, 1995
6. Cruz J, Minoja G, Okuchi K: Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial. Neurosurgery 49:864-871, 2001
7. Cruz J, Minoja G, Okuchi K: Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery 51:628-637, 2002
8. Cruz J, Minoja G, Okuchi K, Facco E: Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg 100:376-383, 2004
9. Fortune JB, Feustel PJ, Graca L, Hasselbarth J, Kuehler DH: Effect of hyperventilation, mannitol, and ventriculostomy drainage on cerebral blood flow after head injury. J Trauma 39:1091-1097, 1995
10. Gemma M, Cozzi S, Tommasino C, Mungo M, Calvi MR, Cipriani A, et al: 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 9:329-334, 1997
11. Hartl R, Bardt TF, Kiening KL, Sarrafzadeh AS, Schneider GH, Unterberg AW: Mannitol decreases ICP but does not improve brain-tissue pO2 in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl 70:40-42, 1997
12. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J: Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial. Crit Care 9:R530-R540, 2005
13. James HE: Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien) 51:161-172, 1980
14. James HE, Langfitt TW, Kumar VS, Ghostine SY: Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir (Wien) 36:189-200, 1977
15. Kerr ME, Weber BB, Sereika SM, Wilberger J, Marion DW: Dose response to cerebrospinal fluid drainage on cerebral perfusion in traumatic brain-injured adults. Neurosurg Focus 11:E1, 2001
16. Kirkpatrick PJ, Smielewski P, Piechnik S, Pickard JD, Czosnyka M: Early effects of mannitol in patients with head injuries assessed using bedside multimodality monitoring. Neurosurgery 39:714-720, 1996
17. Marshall LF, Smith RW, Rauscher LA, Shapiro HM: Mannitol dose requirements in brain-injured patients. J Neurosurg 48: 169-172, 1978
18. McGraw CP, Alexander E Jr, Howard G: Effect of dose and dose schedule on the response of intracranial pressure to mannitol. Surg Neurol 10:127-130, 1978
19. McGraw CP, Howard G: Effect of mannitol on increased intracranial pressure. Neurosurgery 13:269-271, 1983
20. Muizelaar JP, Lutz HAIII, Becker DP: Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 61:700-706, 1984
21. Muizelaar JP, Wei EP, Kontos HA, Becker DP: Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 59:822-828, 1983
22. Rapoport SI: Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 20:217-230, 2000
23. Rosner MJ, Rosner SD, Johnson AH: Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 83: 949-962, 1995
24. Rudehill A, Gordon E, Ohman G, Lindqvist C, Andersson P: Pharmacokinetics and effects of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surgery. J Neurosurg Anesthesiol 5:4-12, 1993
25. Sayre MR, Daily SW, Stern SA, Storer DL, van Loveren HR, Hurst JM: Out-of-hospital administration of mannitol to head-injured patients does not change systolic blood pressure. Acad Emerg Med 3:840-848, 1996
26. Schwarz S, Georgiadis D, Aschoff A, Schwab S: Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 33:136-140, 2002
27. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W: Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 29:1550-1555, 1998
28. Smith HP, Kelly DL Jr, McWhorter JM, Armstrong D, Johnson R, Transou C, et al: Comparison of mannitol regimens in patients with severe head injury undergoing intracranial monitoring. J Neurosurg 65:820-824, 1986
29. Soustiel JF, Mahamid E, Chistyakov A, Shik V, Benenson R, Zaaroor M: Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury - a study of cerebral blood flow and metabolism. Acta Neurochir (Wien):845-851, 2006
30. Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, et al: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 31:1683-1687, 2003
31. Wakai A, Roberts I, Schierhout G: Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 4:CD001049, 2005
32. Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT: Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery 57:727-736, 2005